Sean Wieland
Stock Analyst at Piper Sandler
(1.88)
# 3,223
Out of 5,124 analysts
31
Total ratings
45.45%
Success rate
3.14%
Average return
Main Sectors:
Stocks Rated by Sean Wieland
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OMCL Omnicell | Maintains: Overweight | $57 → $55 | $45.30 | +21.41% | 12 | Aug 11, 2025 | |
| PRVA Privia Health Group | Maintains: Overweight | $35 → $36 | $23.71 | +51.83% | 3 | Aug 11, 2025 | |
| AMWL American Well | Maintains: Overweight | $100 → $120 | $4.91 | +2,343.99% | 2 | Jun 23, 2022 | |
| HIMS Hims & Hers Health | Maintains: Overweight | $8 → $6 | $32.47 | -81.52% | 3 | May 26, 2022 | |
| DOCS Doximity | Maintains: Overweight | $81 → $44 | $44.28 | -0.63% | 2 | May 19, 2022 | |
| IQV IQVIA Holdings | Maintains: Neutral | $261 → $231 | $225.41 | +2.48% | 4 | Feb 18, 2022 | |
| TDOC Teladoc Health | Maintains: Overweight | $305 → $291 | $7.00 | +4,057.14% | 5 | Feb 25, 2021 |
Omnicell
Aug 11, 2025
Maintains: Overweight
Price Target: $57 → $55
Current: $45.30
Upside: +21.41%
Privia Health Group
Aug 11, 2025
Maintains: Overweight
Price Target: $35 → $36
Current: $23.71
Upside: +51.83%
American Well
Jun 23, 2022
Maintains: Overweight
Price Target: $100 → $120
Current: $4.91
Upside: +2,343.99%
Hims & Hers Health
May 26, 2022
Maintains: Overweight
Price Target: $8 → $6
Current: $32.47
Upside: -81.52%
Doximity
May 19, 2022
Maintains: Overweight
Price Target: $81 → $44
Current: $44.28
Upside: -0.63%
IQVIA Holdings
Feb 18, 2022
Maintains: Neutral
Price Target: $261 → $231
Current: $225.41
Upside: +2.48%
Teladoc Health
Feb 25, 2021
Maintains: Overweight
Price Target: $305 → $291
Current: $7.00
Upside: +4,057.14%